Provided by Tiger Fintech (Singapore) Pte. Ltd.

ImmunityBio, Inc.

2.84
+0.17006.37%
Post-market: 2.81-0.0300-1.06%19:59 EDT
Volume:8.77M
Turnover:24.65M
Market Cap:2.51B
PE:-4.94
High:2.91
Open:2.69
Low:2.67
Close:2.67
Loading ...
Mar 08, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Mar 04, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 25, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 24, 2021

Major Issues Report

8-K - Current report
Feb 24, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 10, 2021

Major Issues Report

8-K - Current report
Jan 13, 2021

Major Issues Report

8-K - Current report
Jan 13, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 22, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 22, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 21, 2020

Major Issues Report

8-K - Current report
Dec 21, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 21, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 21, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 21, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Nov 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]